Esaote presents the world premiere of its new MyLab™X90 ultrasound device

An innovative premium system combining outstanding performance with artificial intelligence to optimize workflows and support advanced and interconnected healthcare systems Today Esaote, a leading Italian company in the biomedical sector – in ultrasound, dedicated MRI and medical IT– presents the world premiere of MyLab™X90, its new premium ultrasound system. “Accuracy and precision across the entire image generation chain, […]

3 ก.พ. 66

Accelerating Energy Efficiency Adoption, Deep-tech Startup KrossLinker Develops a Cost-effective Aerogel Insulation

KrossLinker, an energy-efficiency-focused deep-tech advanced material startup, is designing and developing the world’s most insulating nanomaterial, aerogel, that is low-cost, environmentally friendly, and scalable. Efficient and sustainable solutions for the most demanding insulation applications KrossLinker’s first aerogel product, Cryar® Aerogel Board, targets the cold-chain industry, where a positive market growth trend is…

2 ก.พ. 66

Syntach AB announces €17.5M in Blended Funding, Names Patrick NJ Schnegelsberg as New CEO, and Appoints Cansel Isikli as VP of RA/Q

Swedish medtech startup Syntach AB has been awarded up to €15 million in equity financing by European Innovation Council (EIC) for the development of the Syntach Cardiac Support System, a breakthrough device for patients with heart failure. This approval follows the award of a €2.5 million grant from the EIC announced by Syntach AB in […]

1 ก.พ. 66

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer

The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, announced today that the U.S. Food and Drug Administration (FDA) has approved ORSERDU for the treatment of postmenopausal women or adult men, with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. Stemline Therapeutics (“Stemline”), a […]

1 ก.พ. 66

PanopticAI Secures Fundraising Co-Led by Alibaba Hong Kong Entrepreneurs Fund and Gobi Partners GBA to Digitise Remote Healthcare

PanopticAI, Hong Kong’s leading health and wellness monitoring startup, announced a deal closing on a seed-round funding co-led by Alibaba Hong Kong Entrepreneurs Fund (AEF) and Gobi Partners GBA (Gobi GBA), with participation from the HKUST Entrepreneurship Fund (E-Fund) and other renowned investors, marking a promising move in the digital healthcare industry. Founded by researchers […]

30 ม.ค. 66
1 2 3 82